Ocugen, Inc. (OCGN) Financials

OCGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 56.9 million 51.1 million
Dec. 31, 2025 44.3 million 56.5 million
Sept. 30, 2025 57.6 million 54.1 million
June 30, 2025 53.6 million 50.5 million

OCGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -21.8 million 3.4 million
Dec. 31, 2025 -14.0 million 2.0 million
Sept. 30, 2025 -13.0 million 2.0 million
June 30, 2025 -10.8 million 1.8 million

OCGN Net Income

No data available :(

OCGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 31.9 million 24.2 million 3.3 million
Dec. 31, 2025 18.6 million 27.5 million 3.5 million
Sept. 30, 2025 32.6 million 28.4 million 4.6 million
June 30, 2025 27.0 million 28.0 million 4.8 million

OCGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 320.4 million
Dec. 31, 2025 312.3 million
Sept. 30, 2025 304.0 million
June 30, 2025 292.0 million

OCGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6000 11.3 million 8.1 million -
Dec. 31, 2025 35000 10.7 million 6.1 million -
Sept. 30, 2025 91000 11.1 million 8.2 million -
June 30, 2025 43000 8.4 million 6.8 million -

OCGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.5 million -
Dec. 31, 2025 -193000 -
Sept. 30, 2025 1.8 million -
June 30, 2025 1.4 million -

OCGN

Price: $1.18

52 week price:
0.90
2.73

Earnings Per Share: -0.24 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4.7 million

Market Capitalization: 433.3 million

Links: